INS and type 2 diabetes mellitus: International data from routine clinical practice show that glycaemic control in patients with type 2 diabetes is poor on average, even in patients using insulin: almost 50% of patients in the IMPROVE observational study had HbA1c≥ 9.0% at the baseline visit (13).